Clinical Trial

68Ga-NYM096 PET/CT in Various Kinds of Cancer

Study acronym: NYCRVT
Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, single-center study aimed at evaluating the uptake characteristics of 68Ga-NYM096 PET/CT in various kinds of tumors including primary and metastatic lesions. Based on image analysis, this study will assess the uptake of various kinds of tumors using 68Ga-NYM096 PET/CT. The findings will provide critical insights into the tumor uptake on 68Ga-NYM096 PET/CT to identify the most promising indications for future application.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-20.
Trial Details
NCT Number NCT07144748
Lead Sponsor Peking Union Medical College Hospital
Conditions Cancer
Enrollment 120 participants
Start Date 2025-08-01
Primary Completion 2026-10-01 (estimated)
Study Completion 2027-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-05